Skip to content

Chemours CC Capital investments accrued but not yet paid

Capital investments accrued but not yet paid at other companies

Albemarle logo
AlbemarleALB

Other financials

Income statement

See full
Revenue$1.4B+1.0%
Gross profit$212.0M-10.2%
Net income-$29.0M-480%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$563.0M+21.3%
Total debt$4.4B0.0%
Total equity$215.0M-62.0%
Total assets$7.3B-1.5%

Cash flow

See full
Operating cash flow-$44.0M+60.7%
CapEx$49.0M-41.7%
Free cash flow-$93.0M+52.6%

Valuation

See full
Market cap$3B+63.6%

Profitability

See full
Gross margin15.1%-3.8pp
Net margin-7%-7.3pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemours's capital investments accrued but not yet paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemours's capital investments accrued but not yet paid?
Chemours (CC) reported capital investments accrued but not yet paid of $27M in Q1 2026.
How has Chemours's capital investments accrued but not yet paid changed year-over-year?
Chemours's capital investments accrued but not yet paid increased by 3.8% year-over-year, from $26M to $27M.
What is the long-term trend for Chemours's capital investments accrued but not yet paid?
Over 3 years (2021 to 2025), Chemours's capital investments accrued but not yet paid has grown at a -28.4% compound annual growth rate (CAGR), from $90M to $33M.